Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
53
UXIN Quote, Financials, Valuation and Earnings
Last price:
$4.40
Seasonality move
:
15.69%
Day range:
$4.40 - $5.06
52-week range:
$1.41 - $7.84
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.74x
P/B ratio:
--
Volume:
125.8K
Avg. volume:
79.4K
1-year change:
156.52%
Market cap:
$973.1M
Revenue:
$208.4M
EPS (TTM):
-$1.52
Earnings Data
Next earnings date for UXIN
Nov 25
2025
Most recent earnings per share
--
Missed by --
(Jun 12/2025)
Consensus Estimate
--
(Jun 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
UXIN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/12/2025 | Q1 | -- | $69.3M | -- | -- | -- |
| 11/25/2024 | Q3 | -- | $69.4M | -$0.05 | -- | -- |
| 09/23/2024 | Q2 | -- | $55.8M | -$0.04 | -- | -- |
| 04/25/2024 | Q1 | -- | $44.6M | -$1.43 | -- | -- |
| 12/31/2023 | Q4 | $58.4M | $57M | -$2.50 | -$0.50 | -$2.00 |
| 11/28/2023 | Q3 | $48.7M | $49.2M | -$9.95 | -$0.60 | -$9.35 |
| 08/14/2023 | Q2 | $39M | $41.2M | -$2.57 | -$0.70 | -$1.87 |
| 04/11/2023 | Q1 | $45.5M | $50.2M | -$2.63 | -$0.90 | -$1.73 |
| 03/31/2023 | Q4 | $67.2M | $66.1M | -$1.27 | -$1.20 | -$0.07 |
| 09/30/2022 | Q3 | -- | $90.3M | -$1.75 | -- | -- |
| 06/30/2022 | Q2 | -- | $94.7M | $4.08 | -- | -- |
| 03/31/2022 | Q1 | -- | $79.6M | -$4.25 | -- | -- |
| 03/29/2022 | Q4 | -- | $79.2M | -$2.81 | -- | -- |
| 12/15/2021 | Q3 | -- | $53.4M | -$75.51 | -- | -- |
| 09/24/2021 | Q2 | -- | $43M | -$2.79 | -- | -- |
| 03/31/2021 | Q1 | -- | $30.2M | -$5.09 | -- | -- |
| 12/31/2020 | Q4 | -- | $48.7M | -$7.24 | -- | -- |
| 12/17/2020 | Q3 | -- | $11M | -$11.27 | -- | -- |
| 09/08/2020 | Q2 | -- | $8.8M | $4.23 | -- | -- |
| 03/30/2020 | Q4 | -- | $42.5M | -$46.42 | -- | -- |
| 11/27/2019 | Q3 | -- | $65.8M | -$12.83 | -- | -- |
| 09/23/2019 | Q2 | -- | $64.4M | -$18.47 | -- | -- |
| 06/10/2019 | Q1 | -- | $148.7M | -$14.22 | -- | -- |
| 03/14/2019 | Q4 | -- | -$23.8M | -$15.62 | -- | -- |
| 11/20/2018 | Q3 | -- | $50.8M | -$29.98 | -- | -- |
| 08/22/2018 | Q2 | -- | $43.6M | $25.43 | -- | -- |
| 03/31/2018 | Q1 | -- | $102.1M | -$78.59 | -- | -- |
| 12/31/2017 | Q4 | -- | -$141.9M | -$77.14 | -- | -- |
| 09/30/2017 | Q3 | -- | $81.2M | -$63.81 | -- | -- |
| 06/30/2017 | Q2 | -- | $54M | -$38.38 | -- | -- |
| 03/31/2017 | Q1 | -- | $48.8M | -$32.27 | -- | -- |
Uxin Earnings Questions
-
How Much did Uxin Generate in Revenue Last Quarter?
Uxin reported $69.3M worth of top line sales in its most recent quarter.
-
Did Uxin Beat Earnings Last Quarter?
Uxin announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Uxin Profitable?
Uxin reported $4.9M that represents $0.03 per share over the last quarter.
-
What is the Analyst Consensus for Uxin EPS Next Year?
Uxin's earnings are forecast to decrease from -- per share to -- per share next year representing a decrease of -91.71%.
-
When is Uxin's Earnings Date?
Uxin's next earnings date is November 25, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
